SALVATORE, Giuliana
 Distribuzione geografica
Continente #
NA - Nord America 6.927
EU - Europa 4.038
AS - Asia 1.295
SA - Sud America 263
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 19
OC - Oceania 4
Totale 12.567
Nazione #
US - Stati Uniti d'America 6.890
RU - Federazione Russa 1.552
UA - Ucraina 674
SG - Singapore 465
VN - Vietnam 425
IT - Italia 408
SE - Svezia 345
GB - Regno Unito 304
DE - Germania 289
CN - Cina 283
BR - Brasile 229
FR - Francia 168
FI - Finlandia 92
NL - Olanda 82
HK - Hong Kong 29
PL - Polonia 24
CA - Canada 20
EU - Europa 19
AT - Austria 18
IN - India 18
BE - Belgio 15
IE - Irlanda 13
CZ - Repubblica Ceca 12
AR - Argentina 10
JP - Giappone 10
TR - Turchia 10
MX - Messico 8
PK - Pakistan 7
ZA - Sudafrica 7
EC - Ecuador 6
BD - Bangladesh 5
KR - Corea 5
LV - Lettonia 5
PT - Portogallo 5
BG - Bulgaria 4
CO - Colombia 4
ES - Italia 4
IL - Israele 4
IQ - Iraq 4
MA - Marocco 4
PE - Perù 4
PY - Paraguay 4
RO - Romania 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
BZ - Belize 2
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MC - Monaco 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.567
Città #
Fairfield 965
Woodbridge 707
Houston 587
Chandler 454
Ann Arbor 444
Ashburn 425
Seattle 395
Dong Ket 377
Wilmington 377
Cambridge 327
Dallas 292
Moscow 272
Nyköping 220
Singapore 214
Dearborn 207
The Dalles 195
Jacksonville 177
Boardman 157
Southend 146
Naples 112
Beijing 102
Napoli 76
Princeton 70
Lawrence 64
Groningen 63
Grafing 59
Yubileyny 58
New York 57
Ogden 52
Munich 43
Shanghai 40
San Diego 36
Los Angeles 35
Helsinki 33
Hong Kong 28
Düsseldorf 26
Des Moines 24
Formia 23
Milan 23
São Paulo 22
Ho Chi Minh City 21
London 19
Jinan 17
Norwalk 17
Lauterbourg 15
Brussels 14
Chicago 14
Hefei 14
Rome 14
Kunming 13
Boydton 12
Auburn Hills 11
Dublin 11
Frankfurt am Main 11
Kraków 11
Vienna 11
Boston 10
Nanjing 10
Santa Clara 10
Tokyo 10
Amsterdam 9
Atlanta 9
Hanoi 9
Redmond 9
Warsaw 9
Afragola 8
Bremen 8
Edinburgh 8
Nocera Inferiore 8
Redwood City 8
Brno 7
Shenyang 6
Stockholm 6
Tampa 6
Turku 6
Casoria 5
Chennai 5
Guangzhou 5
Kilburn 5
Montreal 5
Nanchang 5
Nocera Superiore 5
Nuremberg 5
Recife 5
Riga 5
Rio de Janeiro 5
St Louis 5
Bexley 4
Charlotte 4
Curitiba 4
Hangzhou 4
Jundiaí 4
Matawan 4
Portsmouth 4
Salt Lake City 4
Shenzhen 4
Zhengzhou 4
Altavilla Irpina 3
Baku 3
Brooklyn 3
Totale 8.474
Nome #
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 330
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 286
Unveiling the miRNAs responsive to physical activity/exercise training in cancer: A systematic review 268
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 262
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 258
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 254
Long-term recreational football training and health in aging 251
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 241
Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy 226
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. 222
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 222
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 222
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 219
BAY 43-9006 inhibition of oncogenic RET mutants. 216
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 210
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer 207
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA 207
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. 206
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 204
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 202
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes 202
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 198
Different mutations of the RET gene cause different human tumoral diseases 196
Identification of targets of twist1 transcription factor in thyroid cancer cells. 196
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 196
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 190
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 189
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 189
Receptor tyrosine kinase inhibitors in thyroid cancer 187
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 185
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 180
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 178
Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review 178
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 177
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 176
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 174
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 170
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. 170
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 168
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 164
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 164
Morphological ultrasound microimaging of thyroid in living mice 164
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 162
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. 161
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 158
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 156
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 155
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 153
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 153
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype 150
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 145
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 144
Monitoring training in non-professional soccer players by coupling SSGs and GPS technology: effects of pitch size and players role 144
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas 143
Pros and cons of cellular studies in developing new drugs for thyroid cancers 140
miR-622 Is a Novel Potential Biomarker of Breast Carcinoma and Impairs Motility of Breast Cancer Cells Through Targeting NUAK1 Kinase 140
Regular football training down-regulates miR-1303 muscle expression in veterans 139
Molecular biology of the MEN2 gene 136
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 133
Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines 131
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 128
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 123
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 117
Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines 115
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma 111
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 108
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein 106
miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression 103
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 96
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth 76
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 70
Exercise’s impact on lung cancer molecular mechanisms: a current overview 64
Insight into the Role of the miR-584 Family in Human Cancers 59
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review. 50
Aberrant Expression of Non-Coding RNAs in Pediatric T Acute Lymphoblastic Leukemia and Their Potential Application as Biomarkers 47
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting 40
Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells 37
Totale 12.797
Categoria #
all - tutte 52.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.200 0 0 0 0 147 85 148 51 74 154 50 491
2021/2022783 53 140 26 199 16 24 108 53 71 41 47 5
2022/20231.485 144 91 140 172 229 216 56 161 159 44 55 18
2023/2024390 29 29 34 23 11 48 19 14 79 23 26 55
2024/20252.981 60 230 36 60 34 293 624 987 148 114 306 89
2025/2026815 166 294 212 137 6 0 0 0 0 0 0 0
Totale 12.797